Autoimmune Diseases  >>  memantine  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
memantine / Generic mfg.
Memantine-MS, NCT00638833 / 2006-003887-76: Memantine Therapy for Multiple Sclerosis

Terminated
2
20
Europe
Memantine, Ebixa, Placebo
Clinica Universidad de Navarra, Universidad de Navarra, H. Lundbeck A/S
Multiple Sclerosis
03/08
03/08

Download Options